ArticleToxics2026
Atrazine Induces Immunosuppression by Directly Targeting Lysozyme: Molecular Insights from Cellular and Multi-Spectroscopic Approaches in Eisenia Fetida.
Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrazine, a widely distributed and persistent triazine herbicide in the environment, has long raised ecological concerns. Existing research has mainly focused on its endocrine-disrupting effects, while immunotoxicity is a growing but relatively understudied area in atrazine research. By integrating cellular assays, multi-spectroscopy analysis, isothermal titration calorimetry (ITC), and molecular docking, this study reveals a molecular mechanism of atrazine-induced immunosuppression: Atrazine can directly target and inhibit the innate immune protein lysozyme, thereby triggering immunosuppression. In earthworm coelomocytes, atrazine exposure leads to decreased cell viability, loss of lysosomal membrane stability, and increased intracellular lysozyme activity. Further exploration of the molecular mechanism of this impairment reveals that atrazine spontaneously binds in the active site of lysozyme, driven mainly by hydrogen bonds and van der Waals forces. This binding causes the unfolding of the lysozyme protein backbone, rearrangement of the secondary structure, and changes in the microenvironment near tryptophan (Trp), thereby distorting the catalytic conformation, and sterically hindering substrate entry, ultimately resulting in the loss of its original catalytic activity. Collectively, this work demonstrates that atrazine can induce immunosuppression by directly acting on immune proteins, providing a novel mechanistic basis for the immunotoxicity and risk assessment of this herbicide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.